Casandra
Casandra Test Code QD91330Version 1 (DRAFT)
Performing Lab
IGF Binding Protein‑2 (IGFBP‑2)
Clinical Use
Order TestUse
This test measures serum concentration of insulin‑like growth factor binding protein 2 (IGFBP‑2) for clinical assessment in endocrinology and related patient management contexts.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (RIA)
Biomarkers
IGFBP-2
ProteinRIA • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
5-12 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
1 mL
Minimum Volume
0.2 mL
Patient Preparation
Fasting is preferred
Causes for Rejection
Gross hemolysis • Gross lipemia • Received room temperature
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 12 hours |
| Refrigerated | 4 days |
| Frozen | 28 days |
Related Tests
Other tests from different labs that may be relevant
Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2)
ARUP Laboratories
Insulin-like Growth Factor-binding Protein 2 (IGFBP-2) (Endocrine Sciences)
Labcorp
Insulin-Like Growth Factor Binding Protein 1 (IGFBP-1)
ARUP Laboratories
Insulin-like Growth Factor-binding Protein 3 (IGFBP-3)
Labcorp
Insulin-Like Growth Factor-Binding Protein 3, Serum
Mayo Clinic Lab
Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3)
ARUP Laboratories
Insulin-like Growth Factor-binding Protein 1 (IGFBP-1) (Endocrine Sciences)
Labcorp
Insulin-like Growth Factor 1 (IGF-1)
Labcorp
Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 Growth Panel, Serum
Mayo Clinic Lab
Insulin-like Growth Factor-binding Protein-1 (IGFBP-1)
Mayo Clinic Lab